{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:05:34Z","timestamp":1760853934718,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["LP120200557"],"award-info":[{"award-number":["LP120200557"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Federal Ministry of Education and Research","award":["BMBF BioDisc 7; 13GW0024"],"award-info":[{"award-number":["BMBF BioDisc 7; 13GW0024"]}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"crossref","award":["CM1307"],"award-info":[{"award-number":["CM1307"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1839-3","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T01:44:14Z","timestamp":1494380654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Antiplasmodial dihetarylthioethers target the coenzyme A synthesis pathway in Plasmodium falciparum erythrocytic stages"],"prefix":"10.1186","volume":"16","author":[{"given":"Thomas","family":"Weidner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Lucantoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abed","family":"Nasereddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Preu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Dzikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky M.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7041-5322","authenticated-orcid":false,"given":"Conrad","family":"Kunick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"1839_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1475-2875-12-187","volume":"12","author":"JN Burrows","year":"2013","unstructured":"Burrows JN, van Huijsduijnen RH, Mohrle JJ, Oeuvray C, Wells TN. Designing the next generation of medicines for malaria control and eradication. Malar J. 2013;12:187.","journal-title":"Malar J"},{"key":"1839_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nrd4573","volume":"14","author":"TN Wells","year":"2015","unstructured":"Wells TN, van Huijsduijnen RH, Van Voorhis WC. Malaria medicines: a glass half full? Nat Rev Drug Discov. 2015;14:424\u201342.","journal-title":"Nat Rev Drug Discov"},{"key":"1839_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/465297a","volume":"465","author":"DA Fidock","year":"2010","unstructured":"Fidock DA. Drug discovery: priming the antimalarial pipeline. Nature. 2010;465:297\u20138.","journal-title":"Nature"},{"key":"1839_CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.2007.77.193","volume":"77","author":"A Bosman","year":"2007","unstructured":"Bosman A, Mendis KN. A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. Am J Trop Med Hyg. 2007;77:193\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"1839_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"1839_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015;47:226\u201334.","journal-title":"Nat Genet"},{"key":"1839_CR7","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960\u20136.","journal-title":"Lancet"},{"key":"1839_CR8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gnadig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428\u201331.","journal-title":"Science"},{"key":"1839_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1475-2875-8-253","volume":"8","author":"NJ White","year":"2009","unstructured":"White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J. 2009;8:253.","journal-title":"Malar J"},{"key":"1839_CR10","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1371\/journal.ppat.0020022","volume":"2","author":"R Dzikowski","year":"2006","unstructured":"Dzikowski R, Frank M, Deitsch K. Mutually exclusive expression of virulence genes by malaria parasites is regulated independently of antigen production. PLoS Pathog. 2006;2:e22.","journal-title":"PLoS Pathog"},{"key":"1839_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1021\/jm301575n","volume":"56","author":"W Fugel","year":"2013","unstructured":"Fugel W, Oberholzer AE, Gschloessl B, Dzikowski R, Pressburger N, Preu L, et al. 3,6-Diamino-4-(2-halophenyl)-2-benzoylthieno[2,3-b]pyridine-5-carbonitriles are selective inhibitors of Plasmodium falciparum glycogen synthase kinase-3. J Med Chem. 2013;56:264\u201375.","journal-title":"J Med Chem"},{"key":"1839_CR12","unstructured":"Molecular modelling group of the swiss institute of bioinformatics: swiss ADME. 2016. \n                    http:\/\/www.swissadme.ch\n                    \n                  . Accessed 12 Oct 2016."},{"key":"1839_CR13","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem. 2000;43:3714\u20137.","journal-title":"J Med Chem"},{"key":"1839_CR14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1021\/ci990307l","volume":"39","author":"SA Wildman","year":"1999","unstructured":"Wildman SA, Crippen GM. Prediction of physicochemical parameters by atomic contributions. J Chem Inf Comput Sci. 1999;39:868\u201373.","journal-title":"J Chem Inf Comput Sci"},{"key":"1839_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/ci200387c","volume":"52","author":"J Ali","year":"2012","unstructured":"Ali J, Camilleri P, Brown MB, Hutt AJ, Kirton SB. Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area. J Chem Inf Model. 2012;52:420\u20138.","journal-title":"J Chem Inf Model"},{"key":"1839_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"1839_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ejmech.2013.03.065","volume":"64","author":"J Ryczak","year":"2013","unstructured":"Ryczak J, Papini M, Lader A, Nasereddin A, Kopelyanskiy D, Preu L, et al. 2-Arylpaullones are selective antitrypanosomal agents. Eur J Med Chem. 2013;64:396\u2013400.","journal-title":"Eur J Med Chem"},{"key":"1839_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1021\/jm7012166","volume":"51","author":"C Reichwald","year":"2008","unstructured":"Reichwald C, Shimony O, Dunkel U, Sacerdoti-Sierra N, Jaffe CL, Kunick C. 2-(3-aryl-3-oxopropen-1-yl)-9-tert-butyl-paullones: a new antileishmanial chemotype. J Med Chem. 2008;51:659\u201365.","journal-title":"J Med Chem"},{"key":"1839_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/1475-2875-13-343","volume":"13","author":"S Fletcher","year":"2014","unstructured":"Fletcher S, Avery VM. A novel approach for the discovery of chemically diverse anti-malarial compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway. Malar J. 2014;13:343.","journal-title":"Malar J"},{"key":"1839_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4269\/ajtmh.2012.11-0302","volume":"86","author":"S Duffy","year":"2012","unstructured":"Duffy S, Avery VM. Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening. Am J Trop Med Hyg. 2012;86:84\u201392.","journal-title":"Am J Trop Med Hyg"},{"key":"1839_CR21","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1128\/AAC.03265-14","volume":"59","author":"M Chugh","year":"2015","unstructured":"Chugh M, Scheurer C, Sax S, Bilsland E, van Schalkwyk DA, Wicht KJ, et al. Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother. 2015;59:1110\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1839_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2174\/138920008786485100","volume":"9","author":"EH Kerns","year":"2008","unstructured":"Kerns EH, Di L, Carter GT. In vitro solubility assays in drug discovery. Curr Drug Metab. 2008;9:879\u201385.","journal-title":"Curr Drug Metab"},{"key":"1839_CR23","doi-asserted-by":"publisher","first-page":"24904","DOI":"10.1074\/jbc.M109.025312","volume":"284","author":"C Spry","year":"2009","unstructured":"Spry C, Saliba KJ. The human malaria parasite Plasmodium falciparum is not dependent on host coenzyme A biosynthesis. J Biol Chem. 2009;284:24904\u201313.","journal-title":"J Biol Chem"},{"key":"1839_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1752-0509-4-120","volume":"4","author":"C Huthmacher","year":"2010","unstructured":"Huthmacher C, Hoppe A, Bulik S, Holzhutter HG. Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis. BMC Syst Biol. 2010;4:120.","journal-title":"BMC Syst Biol"},{"key":"1839_CR25","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1128\/AAC.49.11.4649-4657.2005","volume":"49","author":"C Spry","year":"2005","unstructured":"Spry C, Chai CL, Kirk K, Saliba KJ. A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites. Antimicrob Agents Chemother. 2005;49:4649\u201357.","journal-title":"Antimicrob Agents Chemother"},{"key":"1839_CR26","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1021\/ml300091c","volume":"3","author":"CD Edlin","year":"2012","unstructured":"Edlin CD, Morgans G, Winks S, Duffy S, Avery VM, Wittlin S, et al. Identification and in vitro ADME assessment of a series of novel anti-malarial agents suitable for hit-to-lead chemistry. ACS Med Chem Lett. 2012;3:570\u20133.","journal-title":"ACS Med Chem Lett"},{"key":"1839_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1021\/ml200135p","volume":"2","author":"F Calderon","year":"2011","unstructured":"Calderon F, Barros D, Bueno JM, Coteron JM, Fernandez E, Gamo FJ, et al. An invitation to open innovation in malaria drug discovery: 47 quality starting points from the TCAMS. ACS Med Chem Lett. 2011;2:741\u20136.","journal-title":"ACS Med Chem Lett"},{"key":"1839_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"FJ Gamo","year":"2010","unstructured":"Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, et al. Thousands of chemical starting points for antimalarial lead identification. Nature. 2010;465:305\u201310.","journal-title":"Nature"},{"key":"1839_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1186\/s13071-016-1860-3","volume":"9","author":"S Fletcher","year":"2016","unstructured":"Fletcher S, Lucantoni L, Sykes ML, Jones AJ, Holleran JP, Saliba KJ, et al. Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway. Parasit Vectors. 2016;9:589.","journal-title":"Parasit Vectors"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1839-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-017-1839-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1839-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:39:54Z","timestamp":1589528394000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1839-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1839"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1839-3","relation":{},"ISSN":["1475-2875"],"issn-type":[{"type":"electronic","value":"1475-2875"}],"subject":[],"published":{"date-parts":[[2017,5,15]]},"assertion":[{"value":"6 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"192"}}